OKLAHOMA CITY, January 16, 2023 — Cytovance Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian and microbial biologics, announces the appointment of Mr. Ping Zhang as Chief Executive Officer.